1.	MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P0334, NCT01501487
2.	Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: JBZ-EnRoute+, EnRoute+, EUDRACT-2010-018612-32, EU-21016, NCT01097265
3.	Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 2009-02-017, NCT01149161
4.	Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: MSLT-II, NIH P01 CA029605, NCT00297895
5.	Intraoperative Gamma Camera for Breast Cancer Surgery Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 4126, NCT00757302
6.	Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma Phase: Phase III Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NEO3-06, NCT00911326
7.	Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients Phase: Phase III Type: Diagnostic Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: FCW001, NCT00952679
8.	Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative Phase: Phase III Type: Diagnostic Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: IMSN001, NCT01642511
9.	Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive Phase: Phase III Type: Diagnostic Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: IMSN002, NCT01668914
10.	Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SERC / IPC 2012-001, NCT01717131
11.	Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: Z0011-China, NCT01796444
12.	Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer Phase: Phase II Type: Diagnostic Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TMH/115/2003, No.5/13/66/2003-NCD-III, NCT00128362
13.	Axillary Reverse Mapping Phase: Phase II Type: Treatment Status: Active Age: 18 to 100 Sponsor: Other Protocol IDs: UAMS 78076, NCT00572481
14.	Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UAMS 04959, NCT00575744
15.	Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0266, NCT00832429
16.	Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CE 08.224, NCT00909441
17.	Breast Lymph Node Mapping Phase: Phase II Type: Diagnostic Status: Approved-not yet active Age: 19 to 100 Sponsor: Other Protocol IDs: H09-00926, NCT01038908
18.	Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: SNUBHGS01, NCT01441310
19.	Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-219, NCT00264602
20.	Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma Phase: Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GSP00-106, NCT00386906
21.	Sentinel Node in Ovarian Cancer Phase: Phase I Type: Diagnostic Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: NL40323.068.12, NCT01734746
22.	Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BRD 05/11-M, NCT00293865
23.	Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 03-0031, NCT00315159
24.	Sentinel Node in Colon Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 3737, NCT00411112
25.	Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: Not specified Sponsor: Other Protocol IDs: CRUK-LCC-06/Q1206/149, EU-20706, NCT00897481